OpenAlex
PricingAboutJobs
Log inGet started
Work

Verbesserung von Betazellfunktion und glykämischer Kontrolle nach einem Jahr Therapie mit Exenatide bei Metformin-behandelten Patienten mit Typ-2-Diabetes

HTML

Year: 2008
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: Diabetologie und Stoffwechsel
DOI: 10.1055/s-2008-1076191
Authors: O Bachmann, C Kazda, MC Bunck, M Diamant, A Cornér, B Eliasson, J Malloy, RM Shaginian, W Deng, DM Kendall, MR Taskinen, U Smith, H Yki-Jarvinen, RJ Heine
Institutions: Eli Lilly (Germany), Amsterdam UMC Location Vrije Universiteit Amsterdam, Helsinki University Hospital, Sahlgrenska University Hospital, Eli Lilly (Netherlands)
Language: German

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: exenatide, type 2 diabetes, beta-cell function, metformin, insulin glargine, C-peptide secretion, arginine stimulation, glycemic control, HbA1c, insulin resistance, incretin-based therapy, weight gain, drug safety, hyperinsulinemic-euglycemic clamp, hyperglycemic clamp, first-phase insulin secretion
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2084066254
FWCI:
Cites:
Cited by:
Related to: 8
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security